ELAN Elanco Animal Health Inc

Price (delayed)

$29.31

Market cap

$13.83B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.57

Enterprise value

$19.3B

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, ...

Highlights

ELAN's equity has soared by 52% YoY and by 25% from the previous quarter
The gross profit has contracted by 11% YoY but it has grown by 2.6% from the previous quarter
Elanco Animal Health's revenue has decreased by 5% YoY but it has increased by 4.2% from the previous quarter
The debt has soared by 199% since the previous quarter and by 160% year-on-year
Elanco Animal Health's net income has plunged by 142% from the previous quarter

Key stats

What are the main financial stats of ELAN
Market
Shares outstanding
471.92M
Market cap
$13.83B
Enterprise value
$19.3B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.4
Price to sales (P/S)
4.64
EV/EBIT
N/A
EV/EBITDA
150.79
EV/Sales
6.61
Earnings
Revenue
$2.92B
EBIT
-$250.1M
EBITDA
$128M
Free cash flow
-$96.9M
Per share
EPS
-$0.57
Free cash flow per share
-$0.21
Book value per share
$20.92
Revenue per share
$6.32
TBVPS
$10.85
Balance sheet
Total assets
$17.24B
Total liabilities
$8.89B
Debt
$6.14B
Equity
$8.34B
Working capital
$1.41B
Liquidity
Debt to equity
0.74
Current ratio
1.75
Quick ratio
0.8
Net debt/EBITDA
42.73
Margins
EBITDA margin
4.4%
Gross margin
49.3%
Net margin
-8.5%
Operating margin
-14.1%
Efficiency
Return on assets
-2.2%
Return on equity
-3.6%
Return on invested capital
-4.6%
Return on capital employed
-1.6%
Return on sales
-8.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ELAN stock price

How has the Elanco Animal Health stock price performed over time
Intraday
-4.18%
1 week
-7.31%
1 month
-5.48%
1 year
5.77%
YTD
-0.48%
QTD
4.94%

Financial performance

How have Elanco Animal Health's revenue and profit performed over time
Revenue
$2.92B
Gross profit
$1.44B
Operating income
-$412.9M
Net income
-$246.8M
Gross margin
49.3%
Net margin
-8.5%
Elanco Animal Health's net income has plunged by 142% from the previous quarter
The net margin has dropped by 136% since the previous quarter
The gross profit has contracted by 11% YoY but it has grown by 2.6% from the previous quarter
The gross margin has contracted by 6% YoY

Growth

What is Elanco Animal Health's growth rate over time

Valuation

What is Elanco Animal Health stock price valuation
P/E
N/A
P/B
1.4
P/S
4.64
EV/EBIT
N/A
EV/EBITDA
150.79
EV/Sales
6.61
The company's EPS has shrunk by 128% QoQ
ELAN's equity has soared by 52% YoY and by 25% from the previous quarter
The price to book (P/B) is 7% lower than the last 4 quarters average of 1.5
ELAN's P/S is 33% above its last 4 quarters average of 3.5
Elanco Animal Health's revenue has decreased by 5% YoY but it has increased by 4.2% from the previous quarter

Efficiency

How efficient is Elanco Animal Health business performance
The company's return on sales has shrunk by 187% QoQ
Elanco Animal Health's ROIC has plunged by 156% from the previous quarter
Elanco Animal Health's ROE has plunged by 112% from the previous quarter
The company's return on assets has shrunk by 100% QoQ

Dividends

What is ELAN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ELAN.

Financial health

How did Elanco Animal Health financials performed over time
Elanco Animal Health's total assets is 94% higher than its total liabilities
The company's total liabilities has surged by 176% QoQ and by 167% YoY
Elanco Animal Health's total assets has surged by 95% YoY and by 75% QoQ
The debt is 26% smaller than the equity
The debt has soared by 199% since the previous quarter and by 160% year-on-year
The debt to equity has surged by 139% since the previous quarter and by 72% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.